Page last updated: 2024-08-23

diaziquone and Astrocytoma

diaziquone has been researched along with Astrocytoma in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (85.71)	18.7374
1990's	1 (14.29)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bedikian, AY; Benjamin, RS; Burgess, MA; Feun, LG; Fields, WS; Leavens, ME; Obbens, EA; Savaraj, N; Stewart, DJ; Yung, WK	1
Barranco, SC; Boerwinkle, WR; Howell, KA; Rubin, NH; Schechter, GA	1
Dowling, S; Gaspar, L; Halperin, EC; Herndon, J; Imperato, J; Salter, M	1
Coleman, RE; Djang, WT; Falletta, JM; Friedman, HS; Halperin, EC; Kurtzberg, J; Longee, DC; Oakes, WJ; Schold, SC	1
Al Sarraf, M; Austin, D; Decker, DA; Kresge, C; Wilner, HI	1
Bender, JF; Chaffee, B; Ensminger, WD; Gebarski, S; Greenberg, HS; Grillo-Lopez, AJ; Layton, PB; Meyer, M	1
Albright, RE; Bullard, DE; Burger, PC; Cairncross, JG; DeLong, ER; Friedman, HS; Khandekar, JD; Mahaley, MS; Schold, SC; Vick, NA	1

Trials

1 trial(s) available for diaziquone and Astrocytoma

Article	Year
An analysis of radiotherapy data from the CNS cancer consortium's randomized prospective trial comparing AZQ to BCNU in the treatment of patients with primary malignant brain tumors. The CNS cancer consortium. American journal of clinical oncology, 1993, Volume: 16, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Astrocytoma; Aziridines; Benzoquinones; Brain Neoplasms; Carmustine; Chemotherapy, Adjuvant; Combined Modality Therapy; Dose-Response Relationship, Radiation; Female; Glioblastoma; Glioma; Humans; Male; Middle Aged; Oligodendroglioma; Radiography; Radiotherapy Dosage; Survival Analysis	1993

Article

Year

An analysis of radiotherapy data from the CNS cancer consortium's randomized prospective trial comparing AZQ to BCNU in the treatment of patients with primary malignant brain tumors. The CNS cancer consortium.

American journal of clinical oncology, 1993, Volume: 16, Issue:4

Topics: Adult; Aged; Aged, 80 and over; Astrocytoma; Aziridines; Benzoquinones; Brain Neoplasms; Carmustine; Chemotherapy, Adjuvant; Combined Modality Therapy; Dose-Response Relationship, Radiation; Female; Glioblastoma; Glioma; Humans; Male; Middle Aged; Oligodendroglioma; Radiography; Radiotherapy Dosage; Survival Analysis

1993

Other Studies

6 other study(ies) available for diaziquone and Astrocytoma

Article	Year
A phase II trial of 2,5,-diaziridinyl 3,6-bis (carboethoxy amino) 1,4-benzoquinone (AZQ, NSC 182986) in recurrent primary brain tumors. Journal of neuro-oncology, 1984, Volume: 2, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Astrocytoma; Aziridines; Azirines; Benzoquinones; Bone Marrow Diseases; Brain Neoplasms; Drug Evaluation; Glioblastoma; Glioma; Humans; Middle Aged; Neoplasm Recurrence, Local	1984
Survival and cell cycle kinetics responses of Chinese hamster ovary cells, and clones of human adenocarcinoma of the stomach and astrocytoma to diaziquone (AZQ) in vitro. Investigational new drugs, 1983, Volume: 1, Issue:1 Topics: Adenocarcinoma; Animals; Astrocytoma; Aziridines; Azirines; Benzoquinones; Cell Division; Cell Line; Cell Survival; Cricetinae; Cricetulus; Female; Humans; Kinetics; Ovary; Stomach Neoplasms	1983
Criteria for termination of phase II chemotherapy for patients with progressive or recurrent brain tumor. Neurology, 1989, Volume: 39, Issue:1 Topics: Adolescent; Antineoplastic Agents; Astrocytoma; Aziridines; Benzoquinones; Brain Neoplasms; Cohort Studies; Drug Therapy, Combination; Glioma; Humans; Lomustine; Male; Neoplasm Recurrence, Local; Procarbazine; Tomography, Emission-Computed; Tomography, X-Ray Computed	1989
Phase II study of aziridinylbenzoquinone (AZQ: NSC-182986) in the treatment of malignant gliomas recurrent after radiation. Preliminary report. Journal of neuro-oncology, 1985, Volume: 3, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Astrocytoma; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Evaluation; Female; Follow-Up Studies; Glioblastoma; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma	1985
Phase I-II evaluation of intra-arterial diaziquone for recurrent malignant astrocytomas. Cancer treatment reports, 1986, Volume: 70, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Astrocytoma; Aziridines; Azirines; Benzoquinones; Bone Marrow; Brain Neoplasms; Carmustine; Drug Evaluation; Eye; Female; Glioblastoma; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Neoplasm Recurrence, Local	1986
Phase II diaziquone-based chemotherapy trials in patients with anaplastic supratentorial astrocytic neoplasms. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Aziridines; Benzoquinones; Carmustine; Cerebellar Neoplasms; Child; Dacarbazine; Drug Evaluation; Glioblastoma; Humans; Middle Aged; Neoplasm Recurrence, Local; Statistics as Topic	1987